Brad Swarbrick

Placeholder Person Graphic
Camo Software Japan Co Ltd
Sales & Support Department
Brad Swarbrick is the Owner of Quality by Design Consultancy, specializing in the implementation of PAT solutions into the pharmaceutical and related industries. Brad is also a Co-founder of KAX Group, specializing in multivariate data analysis software solutions. With over 20 years of experience in the application of PAT and chemometrics, including being part of the Pfizer global PAT group, Brad has implemented many systems into pharmaceutical manufacturing operations globally. Brad has a PhD in biospectroscopy from the University of Sydney and is the current pharmaceutical section editor of the Journal of Near Infrared Spectroscopy. Brad is also the author and co-author of a number of textbooks and articles on PAT and chemometrics, including co-authoring the Multivariate Data Analysis in Practice textbook.

Related Articles

Figure 1: Stage 3 of the Validation 4.0 model focuses on continuous verification as a targeted result of QbD.
Technical
Validation 4.0: Case Studies for Oral Solid Dose Manufacturing

Three case studies on Validation 4.0 demonstrate how quality by design (QbD) principles, when applied with digitization, can verify processes in scale-up and technology transfer, and why blend and content uniformity matter for tablet integrity.